IL116228A0 - Monoclonal antibody fragments and pharmaceutical compositions containing them - Google Patents

Monoclonal antibody fragments and pharmaceutical compositions containing them

Info

Publication number
IL116228A0
IL116228A0 IL11622895A IL11622895A IL116228A0 IL 116228 A0 IL116228 A0 IL 116228A0 IL 11622895 A IL11622895 A IL 11622895A IL 11622895 A IL11622895 A IL 11622895A IL 116228 A0 IL116228 A0 IL 116228A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
monoclonal antibody
compositions containing
antibody fragments
fragments
Prior art date
Application number
IL11622895A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL116228A0 publication Critical patent/IL116228A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL11622895A 1994-12-07 1995-12-01 Monoclonal antibody fragments and pharmaceutical compositions containing them IL116228A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07

Publications (1)

Publication Number Publication Date
IL116228A0 true IL116228A0 (en) 1996-03-31

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11622895A IL116228A0 (en) 1994-12-07 1995-12-01 Monoclonal antibody fragments and pharmaceutical compositions containing them

Country Status (19)

Country Link
EP (1) EP0787151A1 (en)
JP (1) JP2001506122A (en)
CN (1) CN1168679A (en)
AR (1) AR002005A1 (en)
AU (1) AU4256096A (en)
BR (1) BR9509902A (en)
CA (1) CA2206471A1 (en)
CO (1) CO4480041A1 (en)
CZ (1) CZ172497A3 (en)
FI (1) FI972430A (en)
HU (1) HUT77342A (en)
IL (1) IL116228A0 (en)
MA (1) MA23739A1 (en)
NO (1) NO972522L (en)
PE (1) PE52996A1 (en)
PL (1) PL320610A1 (en)
TR (1) TR199501542A2 (en)
WO (1) WO1996017874A1 (en)
ZA (1) ZA9510195B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
WO2000012560A1 (en) * 1998-08-28 2000-03-09 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
DE60035337T2 (en) * 2000-05-12 2008-02-28 Gpc Biotech Ag Human peptides / proteins that cause or cause the killing of cells, including lymphoid tumor cells
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
US20030082188A1 (en) 2001-10-11 2003-05-01 Tso J. Yun Treatment of prostate cancer by inhibitors of NCAM2
CA2463634A1 (en) 2001-10-15 2003-04-24 Kirin Beer Kabushiki Kaisha Anti-hla-dr antibody
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
CA2794499A1 (en) * 2010-04-01 2011-10-06 Immumomedics, Inc. Antibody-based depletion of antigen-presenting cells and dendritic cells
KR102647825B1 (en) * 2021-07-22 2024-03-14 서울대학교산학협력단 Anti-HLA-DP monoclonal antibody and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068790B1 (en) * 1981-06-25 1986-02-26 The Board Of Trustees Of The Leland Stanford Junior University Allele specific immunotherapeutic method and dosage form
JPH05502586A (en) * 1989-12-27 1993-05-13 セントカー・インコーポレーテツド Chimeric immunoglobulin against CD4 receptor
SK285046B6 (en) * 1991-07-25 2006-05-04 Idec Pharmaceuticals Corporation Chimeric antibody, that specifically binds to human antigen, pharmaceutical composition in which the antibody is comprised, process of its production and using of it

Also Published As

Publication number Publication date
NO972522D0 (en) 1997-06-03
NO972522L (en) 1997-08-06
EP0787151A1 (en) 1997-08-06
HUT77342A (en) 1998-03-30
JP2001506122A (en) 2001-05-15
FI972430A0 (en) 1997-06-06
CA2206471A1 (en) 1996-06-13
PE52996A1 (en) 1996-12-12
MA23739A1 (en) 1996-07-01
AR002005A1 (en) 1998-01-07
PL320610A1 (en) 1997-10-13
TR199501542A2 (en) 1996-07-21
WO1996017874A1 (en) 1996-06-13
CZ172497A3 (en) 1997-10-15
FI972430A (en) 1997-06-06
AU4256096A (en) 1996-06-26
ZA9510195B (en) 1996-06-07
CN1168679A (en) 1997-12-24
BR9509902A (en) 1997-10-21
CO4480041A1 (en) 1997-07-09
MX9704225A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
IL122370A0 (en) Monkey monoclonal antibodies and pharmaceutical compositions containing them
IL99363A0 (en) Pharmaceutical compositions comprising homoconjugated monoclonal antibodies
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
ZA9510806B (en) Anti-xv-integrin monoclonal antibody
PL314908A1 (en) Humanised antibodies and their application
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
EP0871393A4 (en) In situ immunodetection of antigens
ZA964733B (en) Ob protein compositions and methods
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
IL122717A0 (en) Compounds and pharmaceutical compositions containing them
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
IL116228A0 (en) Monoclonal antibody fragments and pharmaceutical compositions containing them
IL114673A0 (en) Pharmaceutical compositions containing protein
HUP9904199A3 (en) Anti-p53 single-chain antibody fragments and their uses
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
EP0909278A4 (en) Nephropathy-related immunoglobulin g and antibodies for same
IL109232A0 (en) Human monoclonal antibodies and processes and materials for making such antibodies
IL118407A (en) Polymyxin dextran conjugates their preparation and pharmaceutical compositions containing them
IL115882A0 (en) Oxazolyl-and thiazolylimidazo-benzo-and thienodiazepines their manufacture and pharmaceutical compositions containing them
IL114161A0 (en) Amido- quinoxalinediones pharmaceutical compositions containing them and their use
EP0513778A3 (en) Hybrid monoclonal antibodies and compositions containing them
SI1068241T1 (en) Antibody variants and fragments thereof
GB9402593D0 (en) Antibody fragments
GB9311507D0 (en) Antibody fragments
IL112094A0 (en) Novel peptides and pharmaceutical compositions comprising them